Yuvraj

Atreca uses Immune Repertoire Capture technology to develop new vaccines

Atreca and Bill & Melinda Gates Foundation have collaborated to accelerate the discovery and development of new vaccines and therapeutics for human infectious...

US FDA approves Mylan Valsartan and Hydrochlorothiazide tablets

Mylan Pharmaceuticals, a subsidiary of Mylan, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug...

Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA®

Impax Laboratories, Inc.today announced that it and Teva Pharmaceuticals USA, Inc. have reached agreement with Janssen Pharmaceuticals, Inc. and ALZA Corporation (together, “ALZA”)...

Roche leads healthcare sector in key sustainability index for fourth consecutive year

Roche  has been recognised as the most sustainable healthcare company globally in the Dow Jones Sustainability Index (DJSI), for the fourth year in a...

Oncodesign enters into a research collaboration and license agreement with Sanofi for the application of Oncodesign¹s Nanocyclix(R) technology to Sanofi¹s kinase targets

Oncodesign, a drug discovery company and oncology pharmacology service provider, announces today that the company has entered into a strategic research collaboration with...

First efficacy results for dengue vaccine candidate

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced the online publication in The Lancet of clinical study results...

Torax Medical Names Veteran Industry Executive to Lead Global Commercialization Effort

Torax Medical announced today that Eric Masingale has joined the company as Global Vice President of Sales and Marketing. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read